Brief: Acura Pharmaceuticals reports Q2 loss per share $0.18
14/08/2017 21:15
Aug 14 (Reuters) - Acura Pharmaceuticals Inc ACUR.PK
* Acura Pharmaceuticals announces second quarter 2017
financial results
* Q2 loss per share $0.18
Source text for Eikon: ID:nGNXODBAPa
Further company coverage: ACUR.PK
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Acura Pharmaceuticals
See all newsBrief: Acura Pharmaceuticals Received A $250,000 Loan From Abuse Deterrent Pharma, LLC on October 11
Brief: Acura Pharmaceuticals Inc Receives $200,000 Loan From Abuse Deterrent Pharma
Brief: Acura Pharmaceuticals Received $250,000 Loan From AD Pharma For Operations Through End Of April 2023
Brief: Acura Pharmaceuticals, AD Pharma Amend License to LIMITx LTX-03
Insight: Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way